Disc Medicine, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRON research report →
Range $92 – $170
Price Chart
About the company
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases.
- CEO
- John D. Quisel
- IPO
- 2020
- Employees
- 165
- HQ
- Watertown, MA, US
Get TickerSpark's AI analysis on IRON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.88B
- P/E
- -11.81
- Fwd P/E
- 20.47
- PEG
- 0.65
- P/S
- 0.00
- P/B
- 4.84
- EV/EBITDA
- -12.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -36.33%
- ROIC
- -39.94%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-236,022,000
- Net Income
- $-212,184,000-94.0%
- EPS
- $-6.01-51.8%
- OCF Growth
- -92.1%
- FCF Growth
- -92.0%
- 52W High
- $99.50
- 52W Low
- $40.00
- 50D MA
- $71.61
- 200D MA
- $70.89
- Beta
- 2.01
- RSI (14)
- 47
- Avg Volume
- 948.57K
No earnings-call transcripts are available for IRON yet.
- Free Float
- 73.3%
- Shares Outstanding
- 38.39M
- Float Shares
- 28.15M
of shares held by institutions
235 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Fmr LLC | 4.80M | ▼ 91.33K |
| Blackrock, Inc. | 2.53M | ▲ 64.96K |
| Ra Capital Management, L.P. | 2.45M | 0 |
| Jpmorgan Chase & Co | 1.81M | ▼ 63.63K |
| Vanguard Group Inc | 1.77M | ▲ 319.62K |
| Wellington Management Group Llp | 1.76M | ▲ 15.14K |
| Price T Rowe Associates Inc | 1.66M | ▼ 220.16K |
| Vestal Point Capital, LP | 1.64M | ▲ 85.00K |
| State Street Corp | 1.41M | ▼ 243.39K |
| Atlas Venture Life Science Advisors, LLC | 1.38M | ▼ 129.85K |
| Vanguard Capital Management LLC | 1.38M | ▲ 14.99K |
| Tcg Crossover Management, LLC | 1.34M | 0 |
Held by 304 ETFs
Biggest fund positions in IRON by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 10, 26 | Savage William Jacob | sell | 16,035 |
| Oct 19, 26 | Bitterman Kevin | sell | 5,937 |
| Oct 20, 26 | Bitterman Kevin | sell | 2,869 |
| Oct 19, 26 | Bitterman Kevin | sell | 4,942 |
| Oct 20, 26 | Bitterman Kevin | sell | 2,388 |
| Oct 21, 26 | Bitterman Kevin | sell | 13,783 |
| Oct 21, 26 | Bitterman Kevin | sell | 11,470 |
| Oct 19, 26 | Bitterman Kevin | sell | 115 |
| Oct 20, 26 | Bitterman Kevin | sell | 55 |
| Oct 21, 26 | Bitterman Kevin | sell | 266 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IRON coverage
Recent articles, reports, and earnings notes.
No research on IRON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IRON report →Disc Medicine, Inc. (IRON) Upgraded to Buy: Here's What You Should Know
zacks.com · Nov 20
Wall Street Analysts Think Disc Medicine, Inc. (IRON) Could Surge 64.74%: Read This Before Placing a Bet
zacks.com · Nov 20
Disc Medicine, Inc. (IRON) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks Transcript
seekingalpha.com · Nov 17
Disc Medicine, Inc. $IRON Holdings Raised by Alps Advisors Inc.
defenseworld.net · Nov 10
Disc Medicine Reports Third Quarter 2026 Financial Results and Provides Business Update
globenewswire.com · Nov 5
Disc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual Meeting
globenewswire.com · Nov 4
Disc Medicine to Participate in Upcoming Investor Conferences
globenewswire.com · Nov 2
Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock
globenewswire.com · Oct 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.